MetTel, a leader in digital transformation and communications, and TekSynap have secured a three-year contract to transform ...
Aro Biotherapeutics Reports Preliminary Efficacy for ABX1100, a Muscle-targeted GYS1 siRNA, in Patients with Late-Onset Pompe ...
House Secretary General Cheloy Garafil announced on Friday morning, Feb. 6 that her office formally transmitted the two impeachment complaints filed ...
Shareholder/Analyst Call February 5, 2026 3:30 PM ESTCompany ParticipantsRyan Watts - Co-Founder, President, CEO ...
An examination of Bengaluru's Namma 112 shows how phased technology upgrades, infrastructure changes, and new access tools ...
CAMPBELL, Calif., February 03, 2026--8x8, Inc. (NASDAQ: EGHT) reported financial results for the third quarter of fiscal year ...
Detailed price information for Replimune Group Inc (REPL-Q) from The Globe and Mail including charting and trades.
Insufficient physical activity (PA) among children has become a major global public health concern. The family environment ...
Supraphysiological expression of α-Gal A activity maintained for over a year in longest treated patient as of data cutoff date ~~ Stable ...
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing product candidates to treat CNS diseases. Minerva’s goal is to transform the lives of patients with ...
Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous ...
Background Most minority populations in Europe generally exhibit lower childhood vaccine uptake compared with the general population. Improving uptake in these populations requires contextually ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results